Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
PABLO AIR to Showcase Its Unmanned Systems Technologies at 2023 AUVSI XPONENTIAL 2023-05-08 21:00
EmeTerm Anti Fatigue & Car Sickness Wristband Wins the IF and IDA Design Awards 2023-05-08 21:00
Fibocom Launches 5G Smart Module SC151, Powering up 5G Connectivity for AIoT Industry 2023-05-08 21:00
Hesai to Exhibit Industry-Leading Autonomous Sensor Suite at Xponential 2023 2023-05-08 20:30
The Upcoming Launch of WUBEN X3 EDC Flashlight on Kickstarter: The Perfect Blend of Innovation and Utility 2023-05-08 19:55
Pudu Robotics Secures Hundreds of Millions of Yuan in Series C4 Financing, on Top of $15 Million C3 Round in February 2023-05-08 18:00
mōziware and TeamViewer Join Forces to Offer Integrated AR Digital Solutions Globally 2023-05-08 17:22
ONEUS 9th Mini Album 'PYGMALION' Releases Today (May 8 KST)! A New 5-Member Group… Return of the 'Iconic 4th Generation Performers'! 2023-05-08 17:00
MEDICAL IP Is Creating Medical Digital Twins in Virtual Spaces, Powered by NVIDIA Omniverse 2023-05-08 16:00
Qingdao Listed among "Ten Most Beautiful Cities in China" 2023-05-08 13:05
China Cycle 2023: CST debuts CST COREX two-wheeled tire product, promotes sustainable development for ESG project globally 2023-05-07 12:56
Wait… What? Oscar-winning filmmakers are using this portable projector from JMGO??? 2023-05-06 21:00
Creality Shows an Array of Hyper-speed 3D Printers at RAPID+TCT 2023 2023-05-06 20:00
Will AI Surpass Human Intelligence? 2023-05-06 14:53
Korean executive tells success stories in Xiangtan 2023-05-06 12:24
Japanese couple experience Xiangtan's traditional culture 2023-05-06 12:23
BLUETTI Launches Trade-in Program to Encourage Upgrades and Sustainable Living 2023-05-05 22:06
Wavemaker Partners with GWM to Help Expand Its Brand in Global Markets 2023-05-05 21:00
J&T International Signs Strategic Agreement with HeyTap Technology to Deepen Cooperation in Logistics Financial Services 2023-05-05 14:48
Formosa Pharmaceuticals and AimMax Therapeutics Announce the NDA Submission to the US FDA for APP13007 for the Treatment of Post-Operative Inflammation and Pain following Ocular Surgery 2023-05-05 08:00
1 228 229 230 231 232 983